Interventional Spine, Inc. Completes Sale to DePuy Synthes

Interventional Spine, Inc.

Represented Interventional Spine, Inc. in its sale of substantially all of its assets to DePuy Synthes, a subsidiary of Johnson & Johnson (NYSE: JNJ), for an undisclosed price. Interventional Spine developed, manufactured and marketed implantable devices and related instrumentation for spinal surgery and will continue to provide transitional and development services to DePuy. Read the press release.

The Newport Beach-based team representing Interventional Spine included Jeff EstesJason Lee and Larry Cohn